BACCINO, Francesco Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.990
EU - Europa 2.678
AS - Asia 1.905
SA - Sud America 117
OC - Oceania 63
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.785
Nazione #
US - Stati Uniti d'America 3.888
CN - Cina 1.057
IT - Italia 400
IE - Irlanda 359
FR - Francia 302
SE - Svezia 283
DE - Germania 269
UA - Ucraina 257
KR - Corea 254
FI - Finlandia 247
JP - Giappone 186
GB - Regno Unito 155
SG - Singapore 130
PL - Polonia 114
VN - Vietnam 98
BR - Brasile 96
CA - Canada 90
AU - Australia 58
AT - Austria 57
ES - Italia 54
TW - Taiwan 53
DK - Danimarca 30
IN - India 30
NL - Olanda 29
BE - Belgio 28
CH - Svizzera 24
SA - Arabia Saudita 20
SN - Senegal 17
TR - Turchia 17
HK - Hong Kong 16
RU - Federazione Russa 16
NO - Norvegia 14
PT - Portogallo 12
MO - Macao, regione amministrativa speciale della Cina 11
MX - Messico 11
CO - Colombia 9
EU - Europa 7
GR - Grecia 7
ID - Indonesia 7
IL - Israele 7
AR - Argentina 6
NZ - Nuova Zelanda 5
TH - Thailandia 5
RO - Romania 4
BG - Bulgaria 3
CL - Cile 3
HU - Ungheria 3
IR - Iran 3
MY - Malesia 3
PK - Pakistan 3
RS - Serbia 3
EG - Egitto 2
GE - Georgia 2
MT - Malta 2
MU - Mauritius 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IM - Isola di Man 1
IQ - Iraq 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
NG - Nigeria 1
PE - Perù 1
SI - Slovenia 1
VE - Venezuela 1
Totale 8.785
Città #
Beijing 695
Chandler 475
Dublin 346
Ann Arbor 227
Houston 226
Fairfield 202
Villeurbanne 169
Jacksonville 165
Ashburn 156
Princeton 143
Medford 141
Wilmington 124
Redwood City 106
Warsaw 101
Cambridge 96
Seattle 94
Nyköping 90
Torino 89
Singapore 85
Woodbridge 84
Dearborn 76
Pisa 72
Dong Ket 63
Shanghai 54
Vienna 53
Milan 52
Toronto 44
Taipei 41
Nanjing 38
Boston 34
Boardman 32
Tokyo 32
Guangzhou 31
Seoul 26
Verona 21
Norwalk 20
Falls Church 19
Hefei 19
São Paulo 19
Turin 19
Fremont 18
San Diego 17
Rome 16
Brussels 15
Duncan 15
Jinan 14
Lachine 14
Shenyang 14
Sydney 14
Wuhan 13
Barcelona 12
Indianapolis 12
Chongqing 11
Columbia 11
Macao 11
Madrid 11
New York 11
Brisbane 10
Chicago 10
Hangzhou 10
Melbourne 10
Philadelphia 10
Rochester 10
Silver Spring 10
State College 10
Washington 10
Des Moines 9
Detroit 9
Düsseldorf 9
Florence 9
Phoenix 9
Basel 8
Bruino 8
Changsha 8
Hanoi 8
Helsinki 8
Ottawa 8
Zhengzhou 8
Los Angeles 7
Oslo 7
Piemonte 7
Bogotá 6
Columbus 6
Dijon 6
Fuzhou 6
Kunming 6
Montréal 6
Moscow 6
Mumbai 6
Nanchang 6
Xian 6
Amsterdam 5
Brookline 5
Buenos Aires 5
Chengdu 5
Edmonton 5
Erlangen 5
Fontana 5
Hong Kong 5
Kraków 5
Totale 5.125
Nome #
Coming back: autophagy in cachexia 431
ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia 428
Autophagic degradation contributes to muscle wasting in cancer cachexia 400
Novel investigational drugs mimicking exercise for the treatment of cachexia 396
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells 293
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression 236
Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha 214
MuRF-1 and p-GSK3β expression in muscle atrophy of liver cirrhosis 211
Mechanism-based therapeutic approaches to cachexia 203
Changes in myostatin signaling in non weight-losing cancer patients 198
Combined approach to counteract experimental cancer cachexia: eicosapentenoic acid and training exercise 176
Vitamin D and VDR in cancer cachexia and muscle regeneration 167
AUTOPHAGY OF METALLOTHIONEINS PREVENTS TNF-INDUCED OXIDATIVE STRESS AND TOXICITY IN HEPATOMA CELLS 144
Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients 143
Divergent pathways for TNF and C(2)-ceramide toxicity in HTC hepatoma cells 131
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition 130
Interference with Ca 2+ -dependent proteolysis does not alter the course of muscle wasting in experimental cancer cachexia 122
CASPASE 2 ACTIVATION AND ER STRESS DRIVE RAPID JURKAT CELL APOPTOSIS BY CLOFIBRATE 121
In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by Taxol 118
Sphingosine mediates TNFalpha-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells 109
Ca(2+)-dependent proteolysis in muscle wasting. 107
Residual latent activity of acid phosphatase in total rat liver homogenate: a parameter for autophagy? 103
LYSOSOMAL MECHANISMS OF DEATH BY TNF IN HEPATOMA CELLS 103
Residual latent activity of acid phosphatase: autophagy-related variations and effects of cycloheximide. 93
Cellular distribution of lysosomal hydrolase activities in the regenerating rat liver. 91
Acid phosphatase residual latent activity versus lysosome osmotic fragility in rat liver autophagy. 87
Patogenesi dell'ipotrofia muscolare nella cachessia neoplastica: ruolo della via di segnalazione attivata da IGF-1 85
Decreased osmotic fragility of rat liver lysosomes after cycloheximide treatment. 79
Effect of fasting and glucagon on the residual latent activity of acid phosphatase in rat liver. 77
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca2+-dependent proteolytic systems in the muscle of tumour-bearing rats 76
Lysis of rat liver lysosomes through incubation with 1-leucyl-glycine, substrate for a lysosomal dipeptidase. 75
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 74
Differential modulation of TNf alpha-induced cell death by 3-methyladenine, an autophagy inhibitor 72
Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells 72
CALCIUM INFLUX AND [CA2+](I) CHANGES INDUCED BY BASIC FIBROBLAST GROWTH-FACTOR IN BALB-C 3T3 CELLS 72
Anticytokine strategies for the treatment of cancer-related anorexia and cachexia 70
Altered pattern of lipid metabolism in patients with lung cancer 69
Cancer cachexia: metabolic alterations and therapeutic approaches in an experimental model 68
Tissue protein turnover during liver carcinogenesis 67
Cloning and expression of two ornithine decarboxylase forms from HMOA cells. 66
Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia 65
Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells 65
Il TNF determina attivazione delle caspasi, ma morte caspasi-indipendente in cellule di epatoma di ratto 65
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? 65
Rapid and extensive lethal action of clofibrate on hepatoma cells in vitro 64
Ceramide does not mediate TNF toxicity in rat hepatoma cells 63
Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats 63
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice 63
Sustained calcium influx activated by basic fibroblast growth factor in Balb-C 3T3 fibroblasts. 63
Are antioxidants useful to treat skeletal muscle atrophy? 62
High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma 61
Transformation by oncogenic ras-p21 alters the processing and subcellular localization of the lysosomal protease cathepsin D. 60
Potassium and calcium currents and action potentials in mouse Balb/c 3T3 fibroblasts 59
Alterations of lipid and cholesterol metabolism in cahectic tumor-bearing rats are prevented by insulin 59
Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. 58
Anti-TNF treatment interferes with changes in lipid metabolism in a tumour cachexia model 58
Sphingosine mediates TNF-induced lysosomal permeabilization and cell death in hepatoma cells 58
Cancer cachexia: from experimental models to patient management 57
Peroxisome proliferators induce apoptosis in hepatoma cells. 56
Role of mitogen-induced calcium influx in the control of the cell cycle in Balb-c 3T3 fibroblasts 52
Potassium and calcium currents activated by Foetal Calf Serum in Balb-c 3T3 fibroblasts 50
MODULATIONS OF MYOSTATIN IN CANCER CACHEXIA. 49
Mice lacking TNFa receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody 48
Protein kinases in the pathogenesis of muscle wasting 48
Lysosomal mechanisms of death in HTC rat hepatoma cells 47
Effect of dehydroepiandrosterone in the prevention of cancer- and diabetes-induced cachexia 45
Statins, coenzyme Q10 and cachexia: what’s the link? 45
Two currents activated by Epidermal Growth Factor in EGFR-T17 fibroblasts 43
Nutritional support in cancer 43
Endosomal-lysosomal proteolysis mediates death signalling by TNFa, not by etoposide, in L929 fibrosarcoma cells: evidence for an active role of cathepsin D 43
Effect of two aliphatic aldehydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130. 42
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 42
Pharmacological interference with tissue protein hypercatabolism in tumor-bearing rats 42
Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss 41
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130) 41
Regulation of cell turnover in the liver of tumour-bearing rats: occurrence of apoptosis 41
Regulation of protein degradation in neoplastic cells 41
Regulation of protein turnover versus growth state. Studies on the mechanism(s) of initiation of acidic vacuolar proteolysis in cells of stationary ascites hepatoma. 40
Effect of two aliphatic aldheydes, methylglyoxal and 4-hydroxypentenal, on the growth of Yoshida ascites hepatoma AH-130 40
Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals 40
Human and hamster procathepsin D, although equally tagged with mannose-6-phosphates, are differentially targeted to lysosomes in transfected BHK cells. 39
MYOSTATIN EXPRESSION IS UPREGULATED IN CANCER CACHEXIA. 39
Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway 39
Understanding the mechanisms of muscle wasting to improve the management of several pathologies 39
Increased muscle proteasome activity correlates with disease severity in gastric cancer patients 38
Cholesterol metabolism in normal and neoplastic cell proliferation 38
Modulations of the calcineurin/NF-AT pathway in diabetes-induced skeletal muscle atrophy. 37
Skeletal muscle wasting in tumor-bearing rats is associated with MyoD down-regulation 36
Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells 35
Lack of effect of eicosapentenoic acid in preventing cancer cachexia and inhibitng tumor growth 35
Effect of simvastatin administration in an experimental model of cancer cachexia 34
Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma 34
Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model 34
Protein turnover regulations and mechanisms in neoplastic cells and host tissues 34
Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control 33
IGF-1 is down-regulated in experimental cancer cachexia 33
Mechanisms of skeletal muscle depletion in wasting syndromes: role of the ATP-ubiquitin-dependent proteolysis 32
Increased muscle ubiquitin mRNA levels in gastric cancer patients 32
Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. 31
Expression of protein kinase C-beta-1 confers resistance to TNF alpha and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells 31
Totale 8.767
Categoria #
all - tutte 24.349
article - articoli 0
book - libri 0
conference - conferenze 2.122
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.349 59 61 107 156 129 191 167 90 144 103 85 57
2020/2021890 82 63 105 40 62 46 76 43 108 72 57 136
2021/20221.159 53 57 57 56 71 79 91 70 52 89 188 296
2022/20231.466 185 116 40 131 126 380 131 83 147 22 64 41
2023/2024658 63 131 32 39 55 67 18 41 12 55 32 113
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 9.141